Alzheimer\u27s disease (AD) is the most prevalent form of dementia in the elderly population. Accumulation, aggregation, and deposition of amyloid-β (Aβ) peptides generated through proteolytic cleavage of amyloid precursor protein (APP) are likely initiating events in the pathogenesis of AD. While Aβ production is accelerated in familial AD, increasing evidence indicates that impaired clearance of Aβ is responsible for late-onset AD. Because Aβ is mainly generated in neurons, these cells are predicted to have the highest risk of encountering Aβ among all cell types in the brain. However, it is still unclear whether they are also involved in Aβ clearance. Here we show that receptor-mediated endocytosis in neurons by the low-density lipoprote...
Apolipoprotein E (apoE) colocalizes with amyloid-β (Aβ) in Alzheimer disease (AD) plaques and in syn...
BACKGROUND: Clearance at the blood-brain barrier (BBB) plays an important role in removal of Alzheim...
According to the "amyloid hypothesis", the amyloid-beta (A beta) peptide is the toxic intermediate d...
Alzheimer\u27s disease (AD) is the most prevalent form of dementia in the elderly population. Accumu...
The low-density lipoprotein receptor-related protein-1 (LRP1) has a dual role in the metabolism of t...
AbstractLRP (low-density lipoprotein receptor-related protein) is linked to Alzheimer's disease (AD)...
Alzheimer's disease (AD) is characterized by the presence of early intraneuronal deposits of amyloid...
AbstractThe amyloid hypothesis of Alzheimer's disease (AD) maintains that the accumulation of the am...
According to the neurovascular hypothesis, impairment of low-density lipoprotein receptor-related pr...
Alzheimer's disease (AD) is characterized by the presence of early intraneuronal deposits of amyloid...
SummaryMutations in the amyloid precursor protein (APP) cause early-onset Alzheimer's disease (AD), ...
A number of recent investigations about the etiology and patophysiology of Alzheimer’s disease (AD) ...
A deficient transport of amyloid-β across the blood-brain barrier, and its diminished clearance from...
Background: Members of the low-density lipoprotein (LDL) receptor family are involved in endocytosis...
open access articleA deficient transport of amyloid-β across the blood–brain barrier, and its dimini...
Apolipoprotein E (apoE) colocalizes with amyloid-β (Aβ) in Alzheimer disease (AD) plaques and in syn...
BACKGROUND: Clearance at the blood-brain barrier (BBB) plays an important role in removal of Alzheim...
According to the "amyloid hypothesis", the amyloid-beta (A beta) peptide is the toxic intermediate d...
Alzheimer\u27s disease (AD) is the most prevalent form of dementia in the elderly population. Accumu...
The low-density lipoprotein receptor-related protein-1 (LRP1) has a dual role in the metabolism of t...
AbstractLRP (low-density lipoprotein receptor-related protein) is linked to Alzheimer's disease (AD)...
Alzheimer's disease (AD) is characterized by the presence of early intraneuronal deposits of amyloid...
AbstractThe amyloid hypothesis of Alzheimer's disease (AD) maintains that the accumulation of the am...
According to the neurovascular hypothesis, impairment of low-density lipoprotein receptor-related pr...
Alzheimer's disease (AD) is characterized by the presence of early intraneuronal deposits of amyloid...
SummaryMutations in the amyloid precursor protein (APP) cause early-onset Alzheimer's disease (AD), ...
A number of recent investigations about the etiology and patophysiology of Alzheimer’s disease (AD) ...
A deficient transport of amyloid-β across the blood-brain barrier, and its diminished clearance from...
Background: Members of the low-density lipoprotein (LDL) receptor family are involved in endocytosis...
open access articleA deficient transport of amyloid-β across the blood–brain barrier, and its dimini...
Apolipoprotein E (apoE) colocalizes with amyloid-β (Aβ) in Alzheimer disease (AD) plaques and in syn...
BACKGROUND: Clearance at the blood-brain barrier (BBB) plays an important role in removal of Alzheim...
According to the "amyloid hypothesis", the amyloid-beta (A beta) peptide is the toxic intermediate d...